4.7 Review

Hippocampal neurogenesis as a target for the treatment of mental illness: A critical evaluation

Journal

NEUROPHARMACOLOGY
Volume 58, Issue 6, Pages 884-893

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2009.12.013

Keywords

Psychiatric illness; Mental disorders; Dentate gyrus; Subgranular zone; Neurogenic niche; Neural stem cells

Funding

  1. NIH [DA023555, DA023701, DA016765]
  2. NIDA [DA023555, DA023701, DA016765, T32-DA7290]
  3. NINDS [F31-NS064632]
  4. NASA
  5. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS064632] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE ON DRUG ABUSE [K02DA023555, T32DA007290, R21DA023701, R01DA016765] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Over one-quarter of adult Americans are diagnosed with a mental illness like Major Depressive Disorder (MDD), Post-Traumatic Stress Disorder (PTSD), schizophrenia, and Alzheimer's Disease. In addition to the exceptional personal burden these disorders exert on patients and their families, they also have enormous cost to society. Although existing pharmacological and psychosocial treatments alleviate symptoms in many patients, the comorbidity, severity, and intractable nature of mental disorders strongly underscore the need for novel strategies. As the hippocampus is a site of structural and functional pathology in most mental illnesses, a hippocampal-based treatment approach has been proposed to counteract the cognitive deficits and mood dysregulation that are hallmarks of psychiatric disorders. In particular, preclinical and clinical research suggests that hippocampal neurogenesis, the generation of new neurons in the adult dentate gyrus, may be harnessed to treat mental illness. There are obvious applications and allures of this approach; for example, perhaps stimulating hippocampal neurogenesis would reverse the overt and noncontroversial hippocampal atrophy and functional deficits observed in Alzheimer's Disease and schizophrenia, or the more controversial hippocampal deficits seen in MDD and PTSD. However, critical examination suggests that neurogenesis may only correlate with mental illness and treatment, suggesting targeting neurogenesis alone is not a sufficient treatment strategy. Here we review the classic and causative links between adult hippocampal neurogenesis and mental disorders, and provide a critical evaluation of how (and if) our basic knowledge of new neurons in the adult hippocampus might eventually help combat or even prevent mental illness. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available